Enanta Pharmaceuticals Announces Planned Retirement of Longstanding Chief Executive Officer Jay R. Luly, Ph.D. After 23 Years of Company Leadership

$ENTAPress releaseOct 28, 2026, 7:00 AM ETRead the release

Enanta Pharmaceuticals announced that CEO Jay R. Luly will retire as President and CEO by February 1, 2027 after 23 years leading the company. The board has launched a comprehensive search for a successor considering internal and external candidates, and Dr. Luly will stay on as Strategic Advisor through the remainder of 2027 to support the transition.

Key figures

Ceo tenure years: 23
Retirement deadline: February 1, 2027
Strategic advisor through: remainder of 2027

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.